ABBV'S Band of Resistance
ARTICLE SYNOPSIS...AbbVie's (ABBV) stock got slammed after disappointing results on small cell lung cancer drug, Rova-T, test results. The drug was the lead product of Stemcentrix, the biotech company ABBV acquired back in 2016 for $5.8 billion. On Thursday, March 22,
AUTHOR: Stella Osoba, CMTDATE: APR 2018
Band Of The Handheld PCs
ARTICLE SYNOPSIS...You can take notes! You can play games! You can access the Internet! You can get your E-mail -- and you can even be fashionable as you do it all. The newest offerings represent the bargains, best buys, and things to come in the growing market for handhel
AUTHOR: David PennDATE: OCT 2000